The Patent Finder

Karius, Inc.

13 patents currently held · Updated Nov 22, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2036
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 13, 2026
    The maintenance fee for Sample Series to Differentiate Target Nucleic Acids from Contaminant Nucleic Acids (US 11,674,167) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
  • 1 fee due Jan 4, 2027
    The maintenance fee for Synthetic Nucleic Acid Spike-Ins (US 11,692,224) comes due Jan 4, 2027. Unpaid by Jul 6, 2027, it lapses early.
  • 1 fee due Jun 5, 2027
    The maintenance fee for Sample Preparation Methods, Systems and Compositions (US 11,834,711) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 24, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,291,739Compositions and Methods for Enriching Populations of Nucleic Acids
In force
 · High confidence
In forceHigh confidence
US 11,111,520Compositions and Methods for Enriching Populations of Nucleic Acids
In force
 · High confidence
In forceHigh confidence
US 9,976,181Synthetic Nucleic Acid Spike-Ins
In force
 · High confidence
In forceHigh confidence
US 11,078,532Synthetic Nucleic Acid Spike-Ins
In force
 · High confidence
In forceHigh confidence
US 11,692,224Synthetic Nucleic Acid Spike-Ins
In force
 · High confidence
In forceHigh confidence
US 12,595,509Synthetic Nucleic Acid Spike-Ins
In force
 · High confidence
In forceHigh confidence
US 11,180,800Sample Preparation Methods, Systems and Compositions
In force
 · High confidence
In forceHigh confidence
US 11,834,711Sample Preparation Methods, Systems and Compositions
In force
 · High confidence
In forceHigh confidence
US 10,697,008Sample Preparation Methods, Systems and Compositions
In force
 · High confidence
In forceHigh confidence
US 11,674,167Sample Series to Differentiate Target Nucleic Acids from Contaminant Nucleic Acids
In force
 · Medium confidence
In forceMedium confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 4 abandoned

Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.

ApplicationTitleFiledStatus
18/916,558Synthetic Nucleic Acid Spike-InsOct 15, 2024Pending
18/674,513Reduction of Signal from Contaminant Nucleic AcidsMay 24, 2024Pending
18/610,208Microbial Biomarkers in Transplantation and Related MethodsMar 19, 2024Pending
18/527,138Sample Series to Differentiate Target Nucleic Acids from Contaminant Nucleic AcidsDec 1, 2023Pending
18/486,005Sample Preparation Methods, Systems and CompositionsOct 12, 2023Abandoned
18/365,876Metagenomic Next-Generation Sequencing of Microbial Cell-Free Nucleic Acids in Subjects with Lyme DiseaseAug 4, 2023Abandoned
18/349,071Rapid, Non-Invasive Detection and Serial Monitoring of Infections in Subjects Using Microbial Cell-Free DNA SequencingJul 7, 2023Pending
18/338,128Sequencing Microbial Cell-Free Nucleic Acids to Detect Inflammation, Secondary Infection, and Disease SeverityJun 19, 2023Pending
17/553,583Sequencing Microbial Cell-Free DNA from Asymptomatic IndividualsDec 16, 2021Abandoned
16/263,074Reduction of Signal from Contaminant Nucleic AcidsJan 31, 2019Abandoned
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited